Assisted Reproductive Technologies (ART) market size worth $ 50.32 billion by 2027


VANCOUVER, BC, October 19, 2020 / PRNewswire / – Global Assisted Reproductive Technology Market Expected to Be $ 50.32 billion by 2027, according to a new report from Emergen Research. The Assisted Reproductive Technology (ART) market is growing rapidly attributed to the increasing popularity of in vitro fertilization (IVF) (with or without intracytoplasmic sperm injection (ICSI)) and intrauterine artificial insemination (AI -IIU), among others. technologies. The increasing prevalence of ovulation problems, a common cause of infertility in women with irregular or no periods, is a key factor driving the growth of the assisted reproductive technology market and accounts for around 25.0% of cases of infertility in women around the world.

A lack of fertility awareness among younger generations and women opting for fertility treatments could increase the duration of fertility and ultimately require in vitro fertilization, thus fueling the demand for assisted reproductive technologies. Infertility is a multi-faceted problem with social, cultural and economic implications, which can reach threatening proportions in countries with demographic challenges. According to statistics released by WHO, around 8.0-10.0% of couples suffer from some type of infertility problem.

Sexually transmitted diseases (STDs), mainly gonorrhea and chlamydia, are a major cause of infertility in the global population, which in turn is believed to drive the growth of the assisted reproductive technology market. It can cause damage or scarring in the fallopian tubes and blockage and scarring of reproductive structures (eg, ejaculatory ducts), resulting in infertility.

Request a free sample of this research report at:

Highlights of the report

  • In june 2020, Ferring Pharmaceuticals announced the signing of a two-year agreement with Igenomix to research innovative pathological mechanisms and the discovery of targets in conditions associated with infertility and pregnancy, such as preeclampsia, to develop revolutionary diagnostic and therapeutic approaches to meet unmet demand.
  • Frozen non-donor eggs are expected to grow at the fastest rate during the period 2020-2027, due to their established reliability and a higher success rate for pregnancy.
  • Artificial-Intrauterine Insemination does not require the removal of eggs from the body, and therefore the procedure is much less invasive for women who are conceiving. In addition, the process is cost effective compared to IVF, as it does not require egg extraction / laboratory monitoring.
  • Factors such as well-equipped operating and surgical rooms, the presence of highly qualified health professionals, higher purchasing power and improved health coverage for health services from various private insurance schemes and collective, among others, are driving the demand for assisted reproductive technology in hospitals. However, reduced adoption of the latest and most innovative upgrade is responsible for lower market share.
  • Europe, directed by France, Germany, and the United Kingdom, contributed to the largest AHR technologies market share in 2019, attributed to increasing novelties in clinical practice and improved access to fertility treatments in the region. In addition, the region is the first to remove the “experimental” label on cryopreservation of eggs.
  • Major participants include Origio, Cryolab Ltd., Bloom IVF Center, Ferring Pharmaceuticals, Cosmos Biomedical, Irvine Scientific, European Sperm Bank, Ovascience, Parallabs and Microm UK Ltd., among others.

To get industry leading solutions, visit the link below:

Emergen Research has segmented the global Assisted Reproductive Technology (ART) market on the basis of procedure, technology, end-user, and region:

Prospects for the proceedings (revenue, billion USD; 2017-2027)

  • Fresh donor
  • Non-donor fees
  • Frozen donor
  • Frozen non-donor
  • Egg / embryo bank

Technology Outlook (Revenue, USD Billion; 2017-2027)

  • In vitro fertilization (IVF)
    1. In vitro fertilization (IVF) with intracytoplasmic sperm injection (ICSI)
    2. In vitro fertilization (IVF) without intracytoplasmic sperm injection (ICSI)
  • Intrauterine artificial insemination (IA-IUI)
  • Frozen embryo transfer (FET)
  • Others

Order now :

End User Outlook (Revenue, USD Billion; 2017-2027)

  • Hospitals
  • Fertility clinics
  • Others

Regional outlook (revenue, billion USD; 2017-2027)

  • North America
    1. US
    2. Canada
    3. Mexico
  • Europe
    1. Germany
    2. United Kingdom
    3. France
    4. BENELUX
    5. Rest of Europe
  • Asia Pacific
    1. China
    2. Japan
    3. South Korea
    4. Rest of APAC
  • Latin America
    1. Brazil
    2. Rest of LATAM
  • Middle East & Africa
    1. Saudi Arabia
    2. WATER
    3. Rest of the MEA

Find other similar research ideas from Emergen Research:

Wound Cleaning Products Market By Product Type (Wetting Agents, Antiseptics, Moisturizers, Others), By Form Type (Sprays, Solutions, Wipes, Foams, Others), By End User (Hospitals, Outpatient Surgery Centers, Pharmacies and clinics, home care settings) and by regions forecast to 2027

Carrier screening market by medical conditions (pulmonary, hematological and neurological disorders, others), by technology (DNA sequencing, polymerase chain reaction, DNA chips, others), by end user (hospitals, reference laboratories , doctors’ offices and clinics, other) and by Regions Forecast until 2027

Big Data in the healthcare market By component (software, services), by deployment (on-premise, cloud), by type of analysis (predictive analysis, descriptive analysis), by application (clinical analysis, financial analysis), by end user (hospitals and clinics) and by Region, forecast to 2027

Photoacoustic Imaging Market By Product (Imaging Systems, Lasers, Transducers, Contrast Agents, Software), By Application (Oncology, Cardiology, Neurology, Hematology, Others), By End User (Research Institutes, Hospitals & Clinics ) and by region Forecast until 2027

Cancer Imaging Systems Market By Imaging Systems, By Application, By End Users, Forecast To 2027

About Emergen Recherche

At Emergen Research, we believe in the advancement of technology. We are a growing market research and strategy consulting company with a comprehensive knowledge base on cutting-edge and potentially disruptive technologies in the market that are expected to become more prevalent over the next decade.

With cutting-edge market information and a deep understanding of cutting-edge and niche technologies, our solutions answer the questions most relevant to your business needs. A major technological shift has been observed towards the creation of a “circular economy”, fueled by factors such as the increased adoption of bio-based materials, as well as other methods to achieve carbon neutrality. We master the technologies, namely Artificial Intelligence (AI), Augmented Reality (AR), Virtual Reality (VR), Robotic Process Automation (RPA), Smart Manufacturing, Internet of Things (IoT) ), big data analysis, machine learning. , Nanotechnology, Edge Computing, Blockchain Technology, Cloud Computing, Vehicle Electrification, Advanced Maintenance Analytics and Predictive Maintenance, among other popular and emerging technologies.

Contact us:

Eric lee
Business Sales Specialist
Emerging research | Web:
Direct line: +1 (604) 757-9756
E-mail: [email protected]

Read the full press release on:

SOURCE Emerging research

Source link

Leave A Reply

Your email address will not be published.